FDA Seeks to Halt Ad for Drug Crestor
611882
WASHINGTON Dec 22, 2004 - The Food and Drug Administration is seeking to block an ad touting the safety of the cholesterol drug Crestor, calling the claims misleading.
256869
The U.S. Food and Drug Administration warned GlaxoSmithKline Plc  on Thursday over misleading advertisements touting its hypertension drug called Coreg.
287525
The FDA has asked makers of Crestor to stop publishing an ad aimed at patients. The FDA sent a letter to Astra Zeneca on 21st December saying it was concerned that the ad may play down the risks associated with Crestor.
57054
Pfizer Inc., the world&#39;s biggest drugmaker, said it will stop advertising its Celebrex painkiller to consumers after a study showed the drug more than doubled the risk of heart attacks when given in high doses.
34442
Pfizer is the latest drug maker to warn that a product already on the market may pose serious health risks. It took outrage from activists in September to get the Food and Drug Administration to require warning
641280
The Food and Drug Administration should immediately yank Celebrex and Bextra from the market to protect Americans from the drugs' heart risks, according to a petition filed with the agency yesterday by Public Citizen. The petition also requests that the FDA freeze applications for Arcoxia and Prexige -- two painkillers under development -- for the same reason.
119087
Pfizer Inc. says it will immediately pull advertising for its top-selling arthritis pain reliever Celebrex, whose safety was called into question last week after a study found an increased risk of heart attacks in patients taking high dosages of the drug.
79138
Sanofi-Aventis has withdrawn its   marketing application for its Multaq heart arrhythmia treatment   in the European Union, the world's third-largest drugmaker said   on Thursday.
230112
Pfizer Inc. is indefinitely suspending all consumer advertising of its arthritis drug Celebrex, following last week&#39;s revelation of a study that showed high doses caused an increased risk of heart attacks among cancer patients.
574773
A newspaper advertisement for AstraZeneca Plc's cholesterol drug Crestor that touts patient safety is misleading and should no longer be published, regulators warned in a letter released Wednesday.
224819
The U.S. Food and Drug Administration has warned Pfizer Inc.  that television and print advertisements for its painkillers Celebrex and Bextra misled consumers, according to a letter made public on Wednesday.
136406
FDA whistle-blower David Graham says Crestor is the only cholesterol-lowering medication, or statin, that causes acute kidney failure, and that it carries a higher risk of rhabdomyolysis, a potentially life-threatening muscle disorder, than other statins.
31094
The American Academy of Pediatrics said children should be exposed to fewer ads for anti-impotence drugs and more for birth control, and in general need to be shielded from an advertising onslaught.
56941
Pfizer Inc.  on Friday said a Canadian federal court granted its request to prevent Novopharm Ltd. from launching a generic version of Pfizer's Lipitor cholesterol drug until a patent expires in July 2010.
601823
Pfizer does not plan to recall Celebrex, but the company would immediately halt advertising this popular arthritis drug to consumers after a study showed that high doses were
72147
Television advertisements promoting Pfizer Inc.&#39;s impotence drug Viagra omit key information and should be withdrawn, the US Food and Drug Administration (news - web sites) said in a letter to the company released on Monday.
257852
WASHINGTON Oct 29, 2004 - Consumer advocate Dr. Sidney Wolfe renewed his effort Friday to get the anti-cholesterol drug Crestor removed from sale.